Study 3: STEP 5 Trial Duration : 104 weeks (2 years) Findings : Participants on semaglutide lost an average of 15.2% of their body weight, compared to 2.6% in the placebo group
The biological mechanisms that drive weight regain, including hormonal adaptations, metabolic rate reduction, and neurological changes in appetite regulation, persist indefinitely
Transitioning from semaglutide to retatrutide If you are currently on semaglutide , the transition involves stopping semaglutide and allowing a washout period before starting the retatrutide dose schedule
Svetlana Mojsov: Unsung drug developer
Anecdotal reports from healthcare providers and patient communities suggest that mild bruising may occur more frequently in everyday practice, though most cases are minor and resolve without intervention
The study concluded that once-daily oral semaglutide 14 mg is an effective oral treatment option with similar or better efficacy and similar tolerability compared to injectable versions of GLP-1 RAs (receptor antagonists)